Olutasidenib in post-venetoclax patients with mIDH1 AML

Cortes, JE; Schiller, GJ; Numerof, R; Floryk, D; Jonas, BA

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):